Cencora, Inc. (COR)
Health Care / Health Care Distributors
S&P 500$252.67
Below average on several measures. Research carefully.
Weak
Score based on 5 of 5 models — high confidence
Is Cencora, Inc. a Good Investment in 2026?
Cencora, Inc. (COR) scores 4.4 out of 10 on AlphaStocks' composite model, earning a Weak rating. The Buffett model rates Cencora, Inc. as Strong. However, the Greenblatt Magic Formula model rates it Caution — Bottom half (rank 65%). Cencora, Inc. currently trades above its estimated fair value of $197, suggesting limited upside at current prices. Cencora, Inc. ranks #739 out of 1126 stocks in the Health Care sector.
This summary is algorithmically generated and is not financial advice.
Key Metrics
Estimated Fair Value
Trading slightly above estimated fair value.
Model-based estimate, not a price target.
5-Model Analysis
Each model evaluates this stock from a different angle. Combined, they form the composite score above.
Piotroski
Attractive
6/9
Buffett
Strong
Business quality & competitive moat
Graham
Neutral
Significantly above fair value
Lynch
Neutral
PEG 2.8 · Stalwart
Greenblatt
Caution
Bottom half (rank 65%)
Frequently Asked Questions
Is Cencora, Inc. (COR) a good investment?
What is Cencora, Inc.'s Piotroski F-Score?
Is COR overvalued or undervalued?
How does COR compare to other Health Care stocks?
What do investment models say about COR?
Similar Stocks
Compare COR with
Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer